DC
IONS icon

Davenport & Co’s Ionis Pharmaceuticals IONS Stock Holding History

Davenport & Co’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5M Buy
283,960
+45,722
+19% +$3.44M 0.11% 161
2026
Q1 		$17.9M Buy
238,238
+20,341
+9% +$1.61M 0.1% 179
2025
Q4 		$17.2M Buy
217,897
+155,334
+248% +$11.7M 0.09% 175
2025
Q3 		$4.09M Sell
62,563
-2,280
-4% -$111K 0.02% 376
2025
Q2 		$2.56M Buy
64,843
+8,450
+15% +$277K 0.01% 462
2025
Q1 		$1.7M Sell
56,393
-6,347
-10% -$208K 0.01% 526
2024
Q4 		$2.19M Sell
62,740
-12,858
-17% -$481K 0.01% 459
2024
Q3 		$3.03M Sell
75,598
-5,080
-6% -$236K 0.02% 382
2024
Q2 		$3.85M Sell
80,678
-3,250
-4% -$133K 0.02% 330
2024
Q1 		$3.64M Sell
83,928
-2,400
-3% -$114K 0.02% 343
2023
Q4 		$4.37M Sell
86,328
-549
-0.6% -$26.3K 0.03% 295
2023
Q3 		$3.94M Sell
86,877
-940
-1% -$38.8K 0.03% 286
2023
Q2 		$3.6M Buy
87,817
+7,200
+9% +$277K 0.03% 304
2023
Q1 		$2.88M Hold
80,617
– – 0.02% 335
2022
Q4 		$3.04M Sell
80,617
-4,246
-5% -$179K 0.02% 316
2022
Q3 		$3.75M Buy
84,863
+1,545
+2% +$65.1K 0.03% 276
2022
Q2 		$3.08M Sell
83,318
-545
-0.6% -$20.6K 0.03% 307
2022
Q1 		$3.11M Sell
83,863
-800
-0.9% -$26.2K 0.02% 327
2021
Q4 		$2.58M Sell
84,663
-37,640
-31% -$1.18M 0.02% 365
2021
Q3 		$4.1M Buy
122,303
+5,340
+5% +$201K 0.03% 271
2021
Q2 		$4.66M Sell
116,963
-7,775
-6% -$305K 0.04% 224
2021
Q1 		$5.61M Buy
124,738
+2,600
+2% +$145K 0.05% 182
2020
Q4 		$6.91M Sell
122,138
-400
-0.3% -$19.9K 0.07% 159
2020
Q3 		$5.81M Sell
122,538
-4,038
-3% -$224K 0.07% 154
2020
Q2 		$7.46M Sell
126,576
-10,250
-7% -$570K 0.09% 132
2020
Q1 		$6.47M Sell
136,826
-79,086
-37% -$4.41M 0.09% 130
2019
Q4 		$13M Buy
215,912
+69,746
+48% +$4.16M 0.14% 113
2019
Q3 		$9.39M Hold
146,166
– – 0.11% 121
2019
Q2 		$9.39M Sell
146,166
-28,636
-16% -$2.02M 0.11% 118
2019
Q1 		$14.2M Sell
174,802
-51,165
-23% -$3.3M 0.18% 104
2018
Q4 		$12.2M Buy
225,967
+11,008
+5% +$561K 0.17% 111
2018
Q3 		$11.1M Buy
214,959
+34,022
+19% +$1.6M 0.13% 120
2018
Q2 		$7.54M Buy
180,937
+82,247
+83% +$3.65M 0.09% 140
2018
Q1 		$4.35M Buy
98,690
+36,545
+59% +$1.86M 0.05% 163
2017
Q4 		$3.13M Buy
62,145
+29,245
+89% +$1.6M 0.04% 188
2017
Q3 		$1.67M Sell
32,900
-57,618
-64% -$3.02M 0.02% 242
2017
Q2 		$4.6M Buy
90,518
+64,018
+242% +$2.98M 0.06% 155
2017
Q1 		$1.27M Sell
26,500
-160
-0.6% -$7.19K 0.02% 260
2016
Q4 		$1.27M Sell
26,660
-1,500
-5% -$59.4K 0.02% 262
2016
Q3 		$1.03M Sell
28,160
-600
-2% -$18.8K 0.02% 287
2016
Q2 		$670K Buy
28,760
+200
+0.7% +$6.45K 0.01% 355
2016
Q1 		$1.16M Buy
28,560
+483
+2% +$19.6K 0.02% 258
2015
Q4 		$1.74M Buy
28,077
+700
+3% +$37.8K 0.03% 213
2015
Q3 		$1.11M Sell
27,377
-700
-2% -$36.2K 0.02% 262
2015
Q2 		$1.62M Sell
28,077
-56,300
-67% -$3.58M 0.03% 229
2015
Q1 		$5.37M Sell
84,377
-132,958
-61% -$9.02M 0.08% 145
2014
Q4 		$13.4M Sell
217,335
-6,000
-3% -$296K 0.22% 112
2014
Q3 		$8.67M Sell
223,335
-155
-0.1% -$5.49K 0.15% 119
2014
Q2 		$7.7M Buy
223,490
+185,890
+494% +$5.85M 0.13% 119
2014
Q1 		$1.62M Sell
37,600
-550
-1% -$26.7K 0.03% 214
2013
Q4 		$1.52M Buy
38,150
+5,800
+18% +$207K 0.03% 212
2013
Q3 		$1.21M Sell
32,350
-100
-0.3% -$2.99K 0.03% 219
2013
Q2 		$872K Buy
+32,450
New +$690K 0.02% 242

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
CC
Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Davenport & Co's IONS Position: Q2 2026 in Review

Davenport & Co increased its Ionis Pharmaceuticals (IONS) stake by 19% in Q2 2026, buying an estimated $3.44M and bringing the position to 283,960 shares worth $22.5M. The position accounts for 0.11% of the portfolio, ranked #161.

Davenport & Co first reported a position in IONS in Q2 2013 and has held it in 53 quarters since. 43 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Davenport & Co held 283,960 shares of Ionis Pharmaceuticals worth $22.5M as of Q2 2026.
  • Davenport & Co bought 45,722 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.44M.
  • Ionis Pharmaceuticals made up 0.11% of Davenport & Co's portfolio in Q2 2026, its #161 holding.
  • Davenport & Co first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • 43 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.